Barclays
June 26, 2026
European Morning Research Summary
Daily UpdateEquitiesEnergyConsumer Discretionary
This Barclays morning note summarizes Q2 earnings previews and target price adjustments across European equities. Key coverage includes updates on Evonik, RWE, Merck KGaA, and various consumer and retail companies.
Key Takeaways
- 1.Evonik Q2 results beat consensus by 7% due to stronger methionine pricing.
- 2.RWE target price increased to EUR 68 following the strategic Amprion stake acquisition.
- 3.Merck KGaA acquiring Bio-Techne for $11bn; while it adds growth, it introduces near-term EPS dilution.
Table of Contents
- Summary of Changes
- Company Research
- Industry Research
- Publications Summary
- Basic Industries
- European Chemicals & Ingredients
- Consumer
- Financial Services
- Healthcare
- Industrials
- Internet & Media
- Power & Utilities
- Retail
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Anil Shenoy
Securities
RACE.MIRWEG.DE
Themes
AI Impact on Internet TrafficQ2 Earnings Season Preview
Regions
EuropeAsia PacificGermanyFranceBrazil